Symbole | Capitalisation boursière | Prix | Variation % | Volume | Volume Rel | P/E | BPA dil TTM | Croissance dil du BPA YoY TTM | Rendement du Dividende % TTM | Secteur | Note de l'analyste |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 726,012 T ARS | 18 950,000 ARS | −3,07% | 4,455 K | 0,84 | — | — | — | — | Technologie de la santé | — |
LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 726,012 T ARS | 14,650 USD | −2,01% | 30 | 0,16 | — | — | — | — | Technologie de la santé | — |
DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 357,397 T ARS | 1 580,000 ARS | 0,00% | 2 | 0,10 | — | — | — | — | Technologie de la santé | — |
JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 357,397 T ARS | 14 125,000 ARS | −0,18% | 18,412 K | 1,18 | 50,69 | 278,68 ARS | +367,55% | 0,90% | Technologie de la santé | — |
DJN3DJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 357,397 T ARS | 1,320 USD | 0,00% | 20 | — | — | — | — | — | Technologie de la santé | — |
JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 357,397 T ARS | 10,700 USD | +0,94% | 529 | 0,76 | 54,85 | 278,68 ARS | −6,49% | 0,90% | Technologie de la santé | — |
ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 299,245 T ARS | 24 400,000 ARS | +0,41% | 13,826 K | 9,03 | 13,28 | 1 837,67 ARS | +125,28% | 0,99% | Technologie de la santé | — |
ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 299,245 T ARS | 18,450 USD | +1,37% | 23 | 0,38 | 14,34 | 1 837,67 ARS | −54,94% | 0,99% | Technologie de la santé | — |
MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 296,515 T ARS | 33 050,000 ARS | −0,90% | 74 | 0,16 | — | — | — | — | Technologie de la santé | — |
MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 296,515 T ARS | 25,700 USD | +5,54% | 50 | 3,57 | — | — | — | — | Technologie de la santé | — |
AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 223,485 T ARS | 51 600,000 ARS | −0,77% | 94 | 0,20 | 92,00 | 560,88 ARS | +283,52% | 0,82% | Technologie de la santé | — |
AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 223,485 T ARS | 40,500 USD | +3,85% | 10 | 1,39 | 103,15 | 560,88 ARS | −23,30% | 0,82% | Technologie de la santé | — |
NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 202,419 T ARS | 36 350,000 ARS | −0,34% | 4 | 0,03 | — | — | — | — | Technologie de la santé | — |
AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 166,819 T ARS | 14 625,000 ARS | −1,18% | 155 | 0,21 | 71,25 | 205,27 ARS | −12,12% | 1,38% | Technologie de la santé | — |
AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 166,819 T ARS | 11,500 USD | −1,71% | 1 | 0,09 | 47,97 | 205,27 ARS | −76,62% | 1,38% | Technologie de la santé | — |
PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 159,086 T ARS | 10 150,000 ARS | +0,50% | 42,421 K | 1,88 | — | — | — | — | Technologie de la santé | — |
PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 159,086 T ARS | 7,750 USD | +0,91% | 1,773 K | 1,21 | — | — | — | — | Technologie de la santé | — |
PFECPFIZER INC CEDEAR EACH 2 REP 1 ORD USD0.05 DR | 159,086 T ARS | 7,200 USD | −70,00% | 4 | 0,02 | — | — | — | — | Technologie de la santé | — |
BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 85,364 T ARS | 22 100,000 ARS | +10,22% | 8,546 K | 2,72 | — | −2 654,79 ARS | −439,64% | 5,17% | Technologie de la santé | — |
BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 85,364 T ARS | 16,700 USD | +19,29% | 6 | 0,48 | — | −2 654,79 ARS | −190,37% | 5,17% | Technologie de la santé | — |
GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 74,268 T ARS | 13 175,000 ARS | +1,35% | 151 | 0,61 | 46,06 | 286,03 ARS | −2,78% | 1,58% | Technologie de la santé | — |
GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 74,268 T ARS | 10,350 USD | 0,00% | 3 | 0,15 | 30,98 | 286,03 ARS | −74,13% | 1,58% | Technologie de la santé | — |
BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 30,804 T ARS | 21 400,000 ARS | −8,15% | 808 | 2,05 | 73,24 | 292,21 ARS | +24,57% | 0,00% | Technologie de la santé | — |
BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 30,804 T ARS | 18,300 USD | +1,67% | 1 | 0,08 | 53,62 | 292,21 ARS | −66,86% | 0,00% | Technologie de la santé | — |
RICHLABORATORIOS RICHMOND SACIF | 76,149 B ARS | 930,000 ARS | −1,38% | 7,565 K | 1,06 | — | −46,54 ARS | — | 0,00% | Technologie de la santé | — |
ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4,203 B ARS | 96,300 ARS | −2,43% | 4,799 K | 0,98 | 7,29 | 13,22 ARS | — | 0,00% | Technologie de la santé | — |